Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Chagas Cardiomyopathy in New Orleans and the Southeastern United States.

Hsu RC, Burak J, Tiwari S, Chakraborti C, Sander GE.

Ochsner J. 2016 Fall;16(3):304-8.

2.

Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension.

Sander GE, Fernandez C, Giles TD.

Expert Rev Cardiovasc Ther. 2016;14(5):563-72. doi: 10.1586/14779072.2016.1167598. Epub 2016 Apr 7. Review.

PMID:
26986445
3.

Stress Cardiomyopathy in the Setting of COPD Exacerbation.

Landefeld K, Saleh Q, Sander GE.

J Investig Med High Impact Case Rep. 2015 Oct 14;3(4):2324709615612847. doi: 10.1177/2324709615612847. eCollection 2015 Oct-Dec.

4.

Prehypertension: Defining the Transitional Phenotype.

Fernandez C, Sander GE, Giles TD.

Curr Hypertens Rep. 2016 Jan;18(1):2. doi: 10.1007/s11906-015-0611-8. Review.

PMID:
26694821
5.

Endothelial Progenitor Cells as a Biomarker for Transitional Phenotypes in Hypertension.

Giles TD, Sander GE.

J Clin Hypertens (Greenwich). 2015 Aug;17(8):580-1. doi: 10.1111/jch.12567. Epub 2015 May 7. No abstract available.

6.

Role of Four-Dimensional Transesophageal Echocardiography in Diagnosis of Mechanical Tricuspid Valve Obstruction Due to Thrombus.

Quevedo HC, Samson R, Li Z, Mohsen G, Helmcke F, Kerut EK, Sander GE.

Echocardiography. 2015 Aug;32(8):1307-10. doi: 10.1111/echo.12953. Epub 2015 Apr 15. No abstract available.

PMID:
25876758
7.

Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension.

Sander GE, Giles TD.

Expert Opin Pharmacother. 2015 Apr;16(5):763-70. doi: 10.1517/14656566.2015.1020790. Review.

PMID:
25747524
8.

Digital plethysmography and arginine metabolism in prehypertension: effect of nebivolol therapy.

Kandavar R, Fernandez C, Sander GE, Kim C, Velaga S, Sukhanov S, Delafontaine P, Egan P, Roffidal LE, Giles TD.

J Clin Hypertens (Greenwich). 2015 Jan;17(1):14-9. doi: 10.1111/jch.12451. Epub 2014 Dec 15.

9.

Secondary hypertension: Drugs and herbal preparations that increase pressure.

Sander GE.

J Am Soc Hypertens. 2014 Dec;8(12):946-8. doi: 10.1016/j.jash.2014.10.006. Epub 2014 Oct 18. Review. No abstract available.

PMID:
25492840
10.

Vascular stiffness is a biomarker of global cardiovascular risk.

Sander GE, Giles TD.

J Clin Hypertens (Greenwich). 2014 Sep;16(9):625-6. doi: 10.1111/jch.12380. Epub 2014 Jul 31. No abstract available.

11.

Diastolic blood pressure and hypertension phenotypes: the US Food and Drug Administration has it right.

Giles TD, Sander GE.

J Clin Hypertens (Greenwich). 2013 Mar;15(3):145-6. doi: 10.1111/jch.12053. Epub 2012 Dec 26. No abstract available.

12.

Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandins.

Giles TD, Sander GE, Nossaman BD, Kadowitz PJ.

J Clin Hypertens (Greenwich). 2012 Apr;14(4):198-205. doi: 10.1111/j.1751-7176.2012.00606.x. Review.

13.

The new International Classification of Diseases (ICD-10): the hypertension community needs a greater input.

Giles TD, Sander GE.

J Clin Hypertens (Greenwich). 2012 Jan;14(1):1-2. doi: 10.1111/j.1751-7176.2011.00546.x. No abstract available.

14.

What is the blood pressure goal for the elder patient 75 years of age or older?

Sander GE, Giles TD.

Curr Cardiol Rep. 2011 Dec;13(6):485-91. doi: 10.1007/s11886-011-0222-1.

PMID:
21971761
15.

Resistant hypertension: concepts and approach to management.

Sander GE, Giles TD.

Curr Hypertens Rep. 2011 Oct;13(5):347-55. doi: 10.1007/s11906-011-0226-7. Review.

PMID:
21922182
16.

Histologically measured cardiomyocyte hypertrophy correlates with body height as strongly as with body mass index.

Tracy RE, Sander GE.

Cardiol Res Pract. 2011;2011:658958. doi: 10.4061/2011/658958. Epub 2011 Jun 8.

17.

ECG of the month. Bigeminal rhythm VI.

Obeidou B, Sander GE, Glancy DL.

J La State Med Soc. 2011 Jan-Feb;163(1):9-10. No abstract available.

PMID:
21674999
18.

Thiazide diuretics and β-blockers in the treatment of hypertension in diabetes mellitus.

Sander GE, Giles TD.

J Clin Hypertens (Greenwich). 2011 Apr;13(4):296-300. doi: 10.1111/j.1751-7176.2011.00454.x. No abstract available.

19.

The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.

Kandavar R, Higashi Y, Chen W, Blackstock C, Vaughn C, Sukhanov S, Sander GE, Roffidal LE, Delafontaine P, Giles TD.

J Am Soc Hypertens. 2011 May-Jun;5(3):161-5. doi: 10.1016/j.jash.2010.11.003. Epub 2011 Jan 19.

20.

Atorvastatin induced multiple organ failure.

Kandavar R, Sander GE.

J La State Med Soc. 2010 May-Jun;162(3):159-60.

PMID:
20666169
21.

Effects of thiazolidinediones on blood pressure.

Giles TD, Sander GE.

Curr Hypertens Rep. 2007 Aug;9(4):332-7. Review.

PMID:
17686386
22.

The endocannabinoid system and cardiovascular risk: pathophysiologic role and developing therapeutic interventions.

Sander GE, Giles TD.

Am J Geriatr Cardiol. 2006 Jul-Aug;15(4):255-9. Review. No abstract available.

PMID:
16849895
23.

The need for defining- and redefining- hypertension: beyond the numbers.

Giles TD, Sander GE.

Postgrad Med. 2005 Dec;118(6 Suppl Beta-Blockers):21-5. doi: 10.3810/pgm.12.2005.suppl43.228.

PMID:
19667707
24.

Pathophysiologic, diagnostic, and therapeutic aspects of the metabolic syndrome.

Giles TD, Sander GE.

J Clin Hypertens (Greenwich). 2005 Nov;7(11):669-78. Review.

25.

Medical management of myocardial ischemia.

Sander GE, Giles TD.

Am J Geriatr Cardiol. 2005 Jul-Aug;14(4):205-9. Review. No abstract available.

PMID:
16015063
26.

Alcohol--a cardiovascular drug?

Giles TD, Sander GE.

Am J Geriatr Cardiol. 2005 May-Jun;14(3):154-8. Review. No abstract available.

PMID:
15886543
27.

Diabetes mellitus and heart failure.

Sander GE, Giles TD.

Am Heart Hosp J. 2003 Fall;1(4):273-80. Review.

PMID:
15815121
28.

Heart failure in diabetes mellitus: causal and treatment considerations.

Sander GE, Wilklow FE, Giles TD.

Minerva Cardioangiol. 2004 Dec;52(6):491-503. Review.

29.

Pharmacologic update: treatment of erectile dysfunction in the elderly with phosphodiesterase type 5 inhibitors: cardiovascular implications.

Agarwal P, Sander GE, Giles TD.

Am J Geriatr Cardiol. 2004 Nov-Dec;13(6):332-5. No abstract available.

PMID:
15538074
30.

Hypertension in the elderly.

Sander GE.

Curr Hypertens Rep. 2004 Dec;6(6):469-76. Review.

PMID:
15527693
31.
32.

Ximelagatran: light at the end of the tunnel or the next tunnel?

Sander GE, Giles TD.

Am J Geriatr Cardiol. 2004 Jul-Aug;13(4):221-4. Review. No abstract available.

PMID:
15269571
33.

ALLHAT and ANBP2: what have we learned from recent mega-trials?

Sander GE, Giles TD.

Am J Geriatr Cardiol. 2003 Jul-Aug;12(4):267-71. Review. No abstract available.

PMID:
12888711
34.

Statin therapy in the elderly-the evidence mounts.

Sander GE, Giles TD.

Am J Geriatr Cardiol. 2003 Jan-Feb;12(1):65-7. No abstract available.

PMID:
12502921
35.

Hypertension and lipids: lipid factors in the hypertension syndrome.

Sander GE, Giles TD.

Curr Hypertens Rep. 2002 Dec;4(6):458-63. Review.

PMID:
12419175
36.

HOPE in PROGRESS--a tale of two trials: blood pressure reduction or drug mechanism?

Sander GE, Giles TD.

Am J Geriatr Cardiol. 2002 Sep-Oct;11(5):332-3. Review. No abstract available.

PMID:
12214175
37.

High blood pressure in the geriatric population: treatment considerations.

Sander GE.

Am J Geriatr Cardiol. 2002 Jul-Aug;11(4):223-32. Review.

PMID:
12091771
38.

Noncardiac drugs and QTc interval prolongation: an often unrecognized risk factor for adverse cardiovascular outcomes.

Sander GE, Guillory GS, Giles TD.

Am J Geriatr Cardiol. 2002 May-Jun;11(3):197-202. No abstract available.

PMID:
11986537
39.

Cardiovascular Complications of Collagen Vascular Disease.

Sander GE, Giles TD.

Curr Treat Options Cardiovasc Med. 2002 Apr;4(2):151-159.

PMID:
11858777
41.

Beyond the usual strategies for blood pressure reduction: therapeutic considerations and combination therapies.

Giles TD, Sander GE.

J Clin Hypertens (Greenwich). 2001 Nov-Dec;3(6):346-53. Review.

42.

Atrial fibrillation in the elderly--an increasing problem that mandates aggressive management.

Giles TD, Sander GE.

Am J Geriatr Cardiol. 2001 Sep-Oct;10(5):289-92. Review. No abstract available.

PMID:
11528292
43.

Angiotensin II receptor (AT1) antagonists in heart failure after Val-HeFT--Quo Vadis?

Giles TD, Sander GE.

Am J Geriatr Cardiol. 2001 Jan-Feb;10(1):60-3. Review. No abstract available.

PMID:
11413939
44.

Reawakening of interest in aldosterone and aldosterone antagonists: implications for treatment of cardiovascular disease.

Sander GE.

Am J Geriatr Cardiol. 2001 May-Jun;10(3):166-9. Review. No abstract available.

PMID:
11360844
45.
46.

Relationship between resting metabolic rate and the composition of the fat-free mass.

Sparti A, DeLany JP, de la Bretonne JA, Sander GE, Bray GA.

Metabolism. 1997 Oct;46(10):1225-30.

PMID:
9322812
47.

Preservation of left ventricular function and coronary flow by angiotensin I-converting enzyme inhibition in the hypertensive-diabetic Dahl rat.

Given MB, Lowe RF, Gelvin CR, Sander GE, Giles TD.

Am J Hypertens. 1994 Oct;7(10 Pt 1):919-25.

PMID:
7826556
48.

Acute hypotension alters hemodynamic response to methionine-enkephalin in conscious dogs.

Given MB, Lowe RF, Sander GE, Giles TD.

Peptides. 1993 May-Jun;14(3):445-8.

PMID:
8332544
50.

Comparative effects of nitrendipine and hydrochlorothiazide on calciotropic hormones and bone density in hypertensive patients.

Giles TD, Sander GE, Roffidal LE, Quiroz AC, Mazzu AL.

Am J Hypertens. 1992 Dec;5(12 Pt 1):875-9.

PMID:
1285936

Supplemental Content

Loading ...
Support Center